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Abstract Formation of quercetin quinone/quinone methide
metabolites, reflected by formation of the glutathionyl quercetin
adducts as authentic metabolites, was investigated in an in vitro
cell model (B16F-10 melanoma cells). Results of the present
study clearly indicate the formation of glutathionyl quercetin
adducts in a tyrosinase-containing melanoma cell line, expected
to be representative also for peroxidase-containing mammalian
cells and tissues. The data obtained also support that the adducts
are formed intracellular and subsequently excreted into the
incubation medium and reveal for the first time evidence for the
pro-oxidative metabolism of quercetin in a cellular in vitro
model. & 2002 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
Key words: Quercetin; Quinone/quinone methide;
Melanoma cells ; Glutathionyl adduct; Pro-oxidant
1. Introduction
Quinone and quinone methides from a variety of com-
pounds, including 3P,4P-dihydroxy£avonoids, catechol-type
metabolites from estrogens and polycyclic aromatic hydrocar-
bons, and compounds like the anticancer drug tamoxifen,
have been classi¢ed as likely candidates for reactive metabo-
lites able to react with cellular macromolecules [1^3]. For
3P,4P-dihydroxy£avonoids, with an intrinsic catechol moiety,
their pro-oxidative quinone/quinone methide chemistry is es-
pecially of importance because of their increasing use as func-
tional food ingredients and food supplements. Recently the
glutathione (GSH) trapping method proved to be an excellent
method to investigate the quinone/quinone methide chemistry
of £avonoids [4^7], including quercetin, known to be muta-
genic in a variety of bacterial and mammalian mutagenicity
tests presumably through its quinone methide-like metabolites
[8^10].
The actual formation of the glutathionyl-£avonoid quinone
adducts and of their corresponding mercapturic acids in a
cellular in vitro or in vivo system, would represent a bioacti-
vation pathway of these supposed bene¢cial functional food
ingredients, comparable to the formation of the glutathionyl
and N-acetylcysteine conjugates of estrogens [11^15]. In addi-
tion, it has been suggested that the urinary levels of mercap-
turic acids can be used as a biomarker for exposure to active
nucleophilic compounds pointing at possible risks for qui-
none-induced tumorigenesis [16^18]. Because the formation
of these adducts would represent a toxic bioactivation path-
way of supposed bene¢cial functional food ingredients, the
detection of these quercetin glutathionyl adducts as authentic
metabolites in cellular in vitro or in vivo models is of impor-
tance. As a ¢rst step in the search for the biological relevance
of quinone methide-type pro-oxidant chemistry of £avonoids
the objective of the present study was to investigate the pos-
sible formation of especially quercetin glutathione adducts as
authentic metabolites in an in vitro cell model. The in vitro
system used consisted of mouse melanoma cancer cells (B16F-
10). These cells were chosen because they have been reported
to contain signi¢cant levels of tyrosinase [19,20]. Tyrosinase,
but also peroxidases, were shown before to catalyze £avonoid
metabolism to quinone/quinone methide-type metabolites
leading to glutathionyl-£avonoid adducts [4^7]. Thus, the
B16F-10 melanoma cell line was considered an excellent mod-
el system to investigate the possible formation of quercetin
glutathionyl adducts in cells exposed to quercetin.
2. Materials and methods
2.1. Materials
Quercetin was obtained from Acros Organics (NJ, USA). Gluta-
thione, reduced form, and tyrosinase (EC 1.14.19.1) (from mushroom)
were purchased from Sigma (St. Louis, MO, USA). All substrates
were of 98^99% purity. Potassium hydrogen phosphate, potassium
dihydrogen phosphate, citric acid, trisodium citrate dihydrate, anhy-
drous sodium carbonate, sodium hydrogen carbonate, and tri£uoro-
acetic acid were purchased from Merck (Darmstadt, Germany). Ace-
tonitrile and methanol were high performance liquid chromatography
(HPLC) grade from Lab-Scan, Analytical Sciences (Dublin, Ireland).
2.2. Synthesis of quercetin quinone methide glutathione conjugates
To a starting solution of glutathione (¢nal concentration of 1 mM)
in 25 mM potassium phosphate pH 7.6 was added tyrosinase to a ¢nal
concentration of 100 U/ml, followed by addition of 150 WM quercetin,
added from a 10 mM stock solution in methanol. Upon 8 min incu-
bation at 37‡C, the incubation mixture was analyzed by HPLC.
2.3. Quercetin exposure and glutathionyl adduct formation
Mouse melanoma cancer cells (B16F-10) were obtained from
ATCC (Manassas, VA, USA). B16F-10 melanoma cells were cultured
in Dulbecco’s modi¢ed Eagle’s medium (DMEM) (obtained from
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Gibco BRL, Grand Island, NY, USA) with 25 mM HEPES, 4500 mg/
l glucose, pyridoxine and without sodium pyruvate, supplemented
with 10% fetal calf serum and 50 mg/l gentamicin (obtained from
Gibco BRL), at 37‡C in a humid atmosphere containing 5% CO2.
For each experiment, approximately 20U104 cells/ml were plated
onto a 24-well tissue cluster (Costar, Cambridge, MA, USA) and
cultured until a semi-con£uent monolayer was obtained (in about
2 days). Cells were exposed to quercetin in quadruplicate for 1 h,
6 h, and 24 h at 37‡C in (a) DMEM medium described above or
(b) Hanks balanced salt solution (HBSS without phenol red and
NaHCO3, obtained from Gibco) to which NaHCO3 was added to a
¢nal concentration of 0.35 g/l. The ¢nal volume of the medium was
0.5 ml. The concentration range of quercetin used throughout the
experiments was 10, 25, 50, 75 and 100 WM. Quercetin was always
added from a freshly prepared 200 times concentrated stock solution
in DMSO. Exposure to quercetin was performed either in the absence
or presence of vitamin C (¢nal concentration of 1 mM) as indicated.
Control incubations were included containing only DMSO at a ¢nal
concentration of 0.5% in medium.
2.4. Analytical HPLC
HPLC was performed with a Waters M600 liquid chromatography
system. Analytical separations were achieved using an Alltima C18
column (4.6U150 mm) (Alltech, Breda, The Netherlands). The col-
umn was eluted at 0.7 ml/min with water containing 0.1% (v/v) tri-
£uoroacetic acid. A linear gradient from 10 to 30% acetonitrile in 12
min was applied, followed by 2 min isocratic elution with 30% aceto-
nitrile. Hereafter a linear gradient from 30 to 100% acetonitrile was
used in 2 min. The percentage of acetonitrile was kept at 100% for
another 3 min. An injection loop of 10 Wl was used. Detection was
carried out with a Waters 996 photodiode array detector measuring
spectra between 200 nm and 450 nm. Chromatograms presented are
based on detection at 290 nm.
2.5. Liquid chromatography/mass spectrometry (LC/MS)
LC/MS analysis was performed to further characterize the peaks in
the HPLC elution pattern. An injection volume of 10 Wl from the
incubation mixture was used and separation of the products was
achieved on a 2.2U150 mm Alltima C18 column (Alltech, Breda,
The Netherlands). A gradient from 10 to 30% acetonitrile in water
containing 0.1% (v/v) tri£uoroacetic acid was applied at a £ow of
0.2 ml/min in 13 min. The percentage of acetonitrile was kept at
30% for 2 min and then increased to 100% in another 2 min. Mass
spectrometric analysis (LCQ ’classic’, ThermoFinnigan, San Jose, CA,
USA) was performed in the positive electrospray mode with the LCQ
’classic’ electrospray interface using a spray voltage of 4.5 kV and a
capillary temperature of 180‡C with nitrogen as sheath and auxiliary
gas.
3. Results
3.1. Incubation of quercetin with tyrosinase in the presence of
glutathione
Fig. 1 shows the HPLC chromatogram of the incubation of
quercetin with tyrosinase in the presence of GSH. Formation
of two major adducts is observed which were previously iden-
ti¢ed as 6-glutathionyl and 8-glutathionyl quercetin hydrated
in their C ring due to tyrosinase catalyzed water addition to
the C2^C3 double bond in ring C [4,5,7]. Fig. 2a and b show
the LC/MS for both metabolites which reveal the formation
of an M+1 peak at m/z 626.0 for both metabolites and these
LC/MS data, together with [1H]NMR characteristics de-
scribed previously [5,7] identify the nature of the metabolites
as indicated in Fig. 1. The HPLC pattern presented in Fig. 1
is di¡erent from those shown in previous studies and reveals
peaks which appear to be broader than in previous patterns
because of di¡erent gradients. The gradient used in the
present study appeared more suitable for detection of the
glutathionyl quercetin adducts in cell line medium which con-
tains several additional compounds. Also, the HPLC peaks of
the GSH adducts broaden to an even further extent upon a
decrease in the concentration (data not shown), as expected in
the cellular incubations.
3.2. Quercetin quinone methide glutathione conjugate formation
in a cellular in vitro model
Fig. 3a, b, and c show the HPLC chromatograms of
DMEM of mouse B16F-10 melanoma cells exposed to 75 WM
quercetin for 0 h, 1 h, and 6 h, respectively. Comparison of
Fig. 1. HPLC chromatogram of the incubation of quercetin with
tyrosinase in the presence of glutathione revealing the formation of
6-glutathionyl quercetin (6-GSQ) and 8-glutathionyl quercetin
(8-GSQ).
Fig. 2. Mass spectra of (a) 6-glutathionyl quercetin and (b) 8-gluta-
thionyl quercetin revealing also the tyrosinase catalyzed H2O addi-
tion to the glutathionyl quercetin adducts, which is in line with liter-
ature data [7,23]. The m/z values indicated are the values for the
(M+1) forms of the structures indicated.
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Fig. 3b and c to Fig. 3a reveals the occurrence of two broad
metabolite peaks with retention times of 9.1 and 11.4 min,
which represent exactly the same retention times as those of
8- and 6-glutathionyl quercetin under the HPLC conditions
applied (Fig. 1). The UV spectra of these two metabolites
reveal an absorbance peak at 299.9 and 295.1 nm, respec-
tively, and disappearance of the absorbance peak at 370.1
nm of quercetin indicating the loss of the conjugation between
the A ring and B ring [21,22]. LC/MS analysis of these two
metabolites reveals an M+1 peak at m/z 626 (Fig. 4a, b). This
implies that retention times, UV spectra, and mass character-
istics of these two metabolites are identical to those of 8- and
6-glutathionyl quercetin. Comparison of Fig. 3b to Fig. 3c
reveals that the intensities of the two metabolite peaks de-
crease in time. After 24 h (HPLC chromatogram not shown),
the presence of these two metabolites as well as of the parent
quercetin were no longer observed indicating the instability of
the metabolites and the full conversion of quercetin under the
in vitro conditions used. The intracellularly formed GSH con-
jugates have been rapidly excreted into the medium since at
the time of 1 h when glutathionyl quercetin concentrations
were highest in the medium, no GSH conjugates could be
detected by HPLC in the corresponding cellular samples
(chromatogram not shown).
3.3. Quercetin glutathione conjugation in the presence of
vitamin C
Fig. 5 presents the HPLC chromatogram pattern of me-
dium of B16F-10 melanoma cells exposed to 75 WM quercetin
for 1 h in the presence of vitamin C (¢nal concentration of
1 mM). This experiment was performed to exclude the possi-
ble formation of the quercetin quinone/quinone methide and
thus the 6- and 8-glutathionyl quercetin adducts due to chem-
ical auto-oxidation of quercetin in the incubation medium.
Comparison of the results presented in Fig. 3b to those in
Fig. 5 reveals that both in the absence and presence of ascor-
bate formation of the 6- and 8-glutathionyl quercetin adducts
was observed to a similar extent. This supports that the
oxidation and glutathione conjugation are not due to an
extracellular auto-oxidation process and can be ascribed to
intracellular oxidation of quercetin by the tyrosinase present
in the melanoma cells. Also the fact that the extracellular
medium does not contain free GSH further supports that
the 6- and 8-glutathionyl quercetin formation occurs intra-
not extracellular, pointing at a true metabolic activation path-
way.
Fig. 3. HPLC chromatograms of DMEM of mouse B16F-10 mela-
noma cells exposed to 75 WM quercetin for (a) 0 h, (b) 1 h, and (c)
6 h.
Fig. 4. Mass spectra of the two metabolites, (a) 6-GSQ and (b)
8-GSQ, detected in the DMEM of mouse B16F-10 melanoma cells
during the exposure of 75 WM quercetin for 1 h. The m/z values in-
dicated are the values for the (M+1) forms of the structures indi-
cated.
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4. Discussion
Quinones represent a class of toxicological intermediates,
which can create a variety of hazardous e¡ects in vivo, includ-
ing acute cytotoxicity, immunotoxicity and carcinogenesis
[24,25]. The mechanisms by which quinones cause these
e¡ects can be quite complex. Quinones are Michael acceptors,
and cellular damage can occur through alkylation of crucial
cellular proteins and/or DNA. For 3P,4P-dihydroxy£avonoids,
with an intrinsic catechol moiety, their pro-oxidant quinone/
quinone methide chemistry is especially of importance because
of their increasing use as functional food ingredients and food
supplements. Therefore, the objective of the present study was
to investigate the possible formation of the quinone/quinone
methide metabolites of quercetin re£ected by the formation of
the glutathionyl quercetin adducts as authentic metabolites in
an in vitro cell model. The cell model chosen consisted of
B16F-10 melanoma cells known to contain signi¢cant
amounts of tyrosinase [19,20]. The catechol-containing £avo-
noids have been shown to be substrates for tyrosinase and to
deplete glutathione and protein thiols in melanoma cells. This
e¡ect might be ascribed to o-quinone formation although the
actual formation of these o-quinones or of the glutathionyl
conjugates derived from them was not demonstrated [19]. Re-
sults of the present study clearly indicate, for the ¢rst time, the
formation of glutathionyl quercetin adducts in an in vitro cell
model, providing direct evidence for the formation of qui-
none/quinone methide-type metabolites of the £avonoid mod-
el compound quercetin. The data obtained also support that
the adducts are formed intracellular and subsequently ex-
creted into the incubation medium.
Thus, the results of the present study reveal for the ¢rst
time direct to be evidence for the pro-oxidative metabolism
of quercetin in a cellular in vitro model, using the tyrosinase-
containing B16F-10 melanoma cell line. However, not only
tyrosinase but also peroxidases have been shown to be able
to generate the quercetin quinone/quinone methide metabo-
lites [4]. This implies that several mammalian cells and tissues
known to contain peroxidase enzyme activities, including
myeloperoxidase, lactoperoxidase, eosinophil peroxidase and
thyroid peroxidase, may show the same formation of querce-
tin quinone/quinone methides as the tyrosinase-containing
B16F-10 cells of the present study. Furthermore, peroxidase
type of oxidation activity of polyphenols has been reported to
be enhanced many-fold in response to estrogen agonists and
may be related to pro-oxidative type of quinoid chemistry of
polyphenols relevant for carcinogenesis [26]. Thus, the actual
detection of quercetin quinone/quinone methide chemistry in
the tyrosinase-containing B16F-10 melanoma cells of the
present study, can be expected to have implications beyond
the in vitro cell model used. Extension of the ¢ndings of the
present study to peroxidase-containing mammalian cell types
and tissues is an important topic for future research. Further-
more, the peroxidase-mediated formation of quercetin qui-
none/quinone methides indicates that upon one-electron oxi-
dation of quercetin, the quercetin semiquinone radicals
apparently rapidly disproportionate to give the two-electron
oxidized quinone and the reduced parent quercetin. This sug-
gests that quercetin quinoid-type metabolites may even be
expected upon one-electron oxidation of quercetin upon its
action as an anti-oxidant. If this would be the case the for-
mation of quercetin quinoid-type metabolites could even be
foreseen in all cellular systems in which quercetin acts as an
electron donating anti-oxidant, although this also remains to
be proven in future studies.
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